Home > Annual Financials > SHUKRA PHARMACEUTICALS

SHUKRA PHARMACEUTICALS Financial Statement Analysis
[BOM: 524632]

The Revenues of SHUKRA PHARMACEUTICALS have decreased by -56.30% YoY .
The Earnings Per Share (EPS) of SHUKRA PHARMACEUTICALS has decreased by -98.70 % YoY.
COMMUNITY POLL
for SHUKRA PHARMACEUTICALS
Please provide your vote to see the results

SHUKRA PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 524632]

StandaloneMar2025
Mar2024
Mar2023
Mar2022
Mar2021
Revenues ₹33 Cr₹75 Cr₹59 Cr₹20 Cr₹11 Cr
Expenses ₹20 Cr₹55 Cr₹53 Cr₹18 Cr₹9.75 Cr
Operating Profit (Excl OI) ₹13 Cr₹19 Cr₹5.36 Cr₹2.89 Cr₹1.44 Cr
Other Income ₹4.21 Cr₹2.82 Cr₹1.20 Cr₹0.08 Cr₹0.36 Cr
Interest ₹0.60 Cr₹0.29 Cr₹0.28 Cr₹0.29 Cr₹0.03 Cr
Depreciation ₹3.01 Cr₹2.05 Cr₹1.84 Cr₹1.66 Cr₹1.47 Cr
Profit Before Tax ₹13 Cr₹20 Cr₹4.44 Cr₹1.02 Cr₹0.10 Cr
Profit After Tax ₹9.58 Cr₹19 Cr₹4.41 Cr₹0.75 Cr₹0.19 Cr
Earnings Per Share (Rs)₹0.22₹16.94₹11.26₹4.79₹1.20
PAT Margin (%)29.3824.867.493.661.68
ROE(%)15.9044.7021.164.701.21
ROCE(%)21.8044.2418.855.790.54
Total Debt/Equity(x)0.070.050.200.210.63

Key Financials

Market Cap : ₹ 2,435.0 Cr
Revenue (TTM) : ₹ 74.8 Cr
Net Profit(TTM) : ₹ 36.0 Cr
EPS (TTM) : ₹ 0.8
P/E (TTM) : 67.6

Industry Peers & Returns1W1M1Y
SHUKRA PHARMACEUTICALS 3.7% 31.1% 91.5%
SUN PHARMACEUTICAL INDUSTRIES -0.4% -3.3% 15.5%
DIVIS LABORATORIES 0.4% 9.9% 55.1%
TORRENT PHARMACEUTICALS -3.4% -4.2% 37.1%
CIPLA 0.5% -3.2% -12.8%
DR REDDYS LABORATORIES 0.9% 0% -11%
MANKIND PHARMA 1.8% -3.1% -11%
LUPIN 2.3% -3.4% 2.4%
ZYDUS LIFESCIENCES 3% 4.3% 8.9%


SHUKRA PHARMACEUTICALS Revenues
[BOM: 524632]

Y-o-Y

-56.30 %

5 Yr CAGR

30.62 %

Years Revenues % Change
Mar2025 ₹33 Cr
-56.30
Mar2024 ₹75 Cr
26.75
Mar2023 ₹59 Cr
187.19
Mar2022 ₹20 Cr
82.98
Mar2021 ₹11 Cr -


SHUKRA PHARMACEUTICALS Operating Profit
[BOM: 524632]

Y-o-Y

-34.39 %

5 Yr CAGR

72.31 %

Years Operating Profit % Change
Mar2025 ₹13 Cr
-34.39
Mar2024 ₹19 Cr
261.79
Mar2023 ₹5.36 Cr
85.83
Mar2022 ₹2.89 Cr
99.86
Mar2021 ₹1.44 Cr -

Operating Margins
Y-o-Y

50.12 %

5 Yr CAGR

31.91 %

Years Operating Margin% % Change
Mar2025 39.06%
50.12
Mar2024 26.02%
185.31
Mar2023 9.12%
-35.27
Mar2022 14.09%
9.22
Mar2021 12.9% -

SHUKRA PHARMACEUTICALS Profit After Tax
[BOM: 524632]

Y-o-Y

-48.35 %

5 Yr CAGR

167.14 %

Years Profit After Tax % Change
Mar2025 ₹9.58 Cr
-48.35
Mar2024 ₹19 Cr
320.63
Mar2023 ₹4.41 Cr
486.82
Mar2022 ₹0.75 Cr
299.47
Mar2021 ₹0.19 Cr -

PAT Margins
Y-o-Y

18.18 %

5 Yr CAGR

104.50 %

Years PAT Margin(%) % Change
Mar2025 29.38 %
18.18
Mar2024 24.86 %
231.91
Mar2023 7.49 %
104.64
Mar2022 3.66 %
117.86
Mar2021 1.68 % -

SHUKRA PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 524632]

Y-o-Y

-98.70 %

5 Yr CAGR

-34.56 %

Years EPS % Change
Mar2025 ₹0.22
-98.70
Mar2024 ₹17
50.44
Mar2023 ₹11
135.07
Mar2022 ₹4.79
299.17
Mar2021 ₹1.20 -

SHUKRA PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 524632]

Y-o-Y

-50.72 %

5 Yr CAGR

152.07 %

Years ROCE % Change
Mar2025 21.8%
-50.72
Mar2024 44.24%
134.69
Mar2023 18.85%
225.56
Mar2022 5.79%
972.22
Mar2021 0.54% -

SHUKRA PHARMACEUTICALS Share Price vs Sensex

Current Share Price : ₹55.2
Current MarketCap: ₹ 2,435.0 Cr
Updated EOD on :Sep 21,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
SHUKRA PHARMACEUTICALS

3.7%

31.1%

91.5%

SENSEX

0.1%

-2.7%

-8.6%

SHUKRA PHARMACEUTICALS related INDICES

BSE Indices1W1M1Y
BSE HEALTHCARE 1.5% 2.8% 15.8%
No NSE index found

You may also like the below Video Courses


FAQ about SHUKRA PHARMACEUTICALS Financials


How the annual revenues of SHUKRA PHARMACEUTICALS have changed ?

The Revenues of SHUKRA PHARMACEUTICALS have decreased by -56.30% YoY .

How the Earnings per Share (EPS) of SHUKRA PHARMACEUTICALS have changed?

The Earnings Per Share (EPS) of SHUKRA PHARMACEUTICALS has decreased by -98.70 % YoY .